Patents by Inventor Ruggero ROSSI

Ruggero ROSSI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF A COMPOSITION COMPRISING MICROORGANISMS TO INCREASE THE INTESTINAL PRODUCTION OF BUTYRIC ACID, FOLIC ACID OR NIACIN AND/OR DECREASE THE INTESTINAL PRODUCTION OF SUCCINIC ACID
    Publication number: 20240050497
    Abstract: Use of a composition comprising bacteria to increase the intestinal production of butyric acid, folic acid or niacin and/or to decrease the intestinal production of succinic acid. Moreover, the present invention relates to the use of said composition for the treatment and/or prevention of an intestinal butyrate- and/or succinate-dependent pathological condition. In particular, for the treatment and/or the prevention of intestinal inflammation, diarrhoea, ulcerative colitis or intestinal colopathies.
    Type: Application
    Filed: October 24, 2023
    Publication date: February 15, 2024
    Inventors: Simone Domenico GUGLIELMETTI, Ruggero ROSSI, Walter FIORE, Andrea BIFFI
  • Probiotics for use in the treatment of diverticulosis and diverticular disease
    Patent number: 11896631
    Abstract: The present invention relates to the use of probiotics to control the inflammatory process of the colon in subjects with structural modifications of the colon wall, preferably in subjects with diverticulosis, and affected by diverticular disease.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: February 13, 2024
    Assignee: ALFASIGMA S.P.A.
    Inventors: Andrea Biffi, Walter Fiore, Ruggero Rossi
  • Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid
    Patent number: 11839634
    Abstract: The present invention relates to the use of a composition comprising bacteria to increase the intestinal production of butyric acid, folic acid or niacin and/or to decrease the intestinal production of succinic acid. Moreover, the present invention relates to the use of said composition for the treatment and/or prevention of an intestinal butyrate- and/or succinate-dependent pathological condition. In particular, for the treatment and/or the prevention of intestinal inflammation, diarrhoea, ulcerative colitis or intestinal colopathies.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: December 12, 2023
    Assignee: ALFASIGMA S.P.A.
    Inventors: Simone Domenico Guglielmetti, Ruggero Rossi, Walter Fiore, Andrea Biffi
  • Medical use of probiotics
    Patent number: 11752179
    Abstract: The present invention relates to the use of a composition based on bacteria and/or yeasts and/or other microorganisms, taken singularly or in combination, for the treatment of abdominal pain by administering to a patient suffering from Irritable Bowel Syndrome (IBS). In particular, the bacteria comprise Lactobacillus paracasei DG strain deposited with the deposit number CNCMI 1572.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: September 12, 2023
    Assignee: ALFASIGMA S.P.A.
    Inventors: Andrea Biffi, Walter Fiore, Ruggero Rossi
  • Composition for use in the treatment of intestinal alterations
    Patent number: 11690889
    Abstract: The present invention relates to a composition which comprises a mixture which comprises or, alternatively, consists of an extract (a) of a fruit of at least one plant of the genus Vaccinium and at least one ingredient (b) acceptable for pharmaceutical or food use and the use thereof in the prevention and/or treatment of diverticular disease or of a pathology deriving therefrom or correlated thereto.
    Type: Grant
    Filed: November 23, 2020
    Date of Patent: July 4, 2023
    Assignee: SOFAR S.P.A.
    Inventors: Andrea Biffi, Ruggero Rossi, Walter Fiore, Silvia Salamina
  • Exopolysaccharides and uses thereof
    Patent number: 11591416
    Abstract: The present invention refers to exopolysaccharide molecules, conditioned media or compositions comprising said molecules or media. Moreover, the present invention refers to use of said exopolysaccharide molecules, conditioned media or compositions as prebiotic, preferably to boost immune system.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: February 28, 2023
    Assignee: SOFAR S.P.A.
    Inventors: Andrea Biffi, Ruggero Rossi, Walter Fiore, Simone Domenico Guglielmetti, Silvia Balzaretti
  • PROBIOTICS FOR USE IN THE TREATMENT OF DIVERTICULOSIS AND DIVERTICULAR DISEASE
    Publication number: 20210236565
    Abstract: The present invention relates to the use of probiotics to control the inflammatory process of the colon in subjects with structural modifications of the colon wall, preferably in subjects with diverticulosis, and affected by diverticular disease.
    Type: Application
    Filed: December 15, 2017
    Publication date: August 5, 2021
    Inventors: Andrea BIFFI, Walter FIORE, Ruggero ROSSI
  • COMPOSITION FOR USE IN THE TREATMENT OF INTESTINAL ALTERATIONS
    Publication number: 20210077558
    Abstract: The present invention relates to a composition which comprises a mixture which comprises or, alternatively, consists of an extract (a) of a fruit of at least one plant of the genus Vaccinium and at least one ingredient (b) acceptable for pharmaceutical or food use and the use thereof in the prevention and/or treatment of diverticular disease or of a pathology deriving therefrom or correlated thereto.
    Type: Application
    Filed: November 23, 2020
    Publication date: March 18, 2021
    Inventors: Andrea Biffi, Ruggero Rossi, Walter Fiore, Silvia Salamina
  • Composition for use in the treatment of intestinal alterations
    Patent number: 10881703
    Abstract: The present invention relates to a composition which comprises a mixture which comprises or, alternatively, consists of an extract (a) of a fruit of at least one plant of the genus Vaccinium and at least one ingredient (b) acceptable for pharmaceutical or food use and the use thereof in the prevention and/or treatment of diverticular disease or of a pathology deriving therefrom or correlated thereto.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: January 5, 2021
    Assignee: SOFAR S.p.A.
    Inventors: Andrea Biffi, Ruggero Rossi, Walter Fiore, Silvia Salamina
  • COMPOSITION FOR USE IN THE TREATMENT OF INTESTINAL ALTERATIONS
    Publication number: 20200061141
    Abstract: The present invention relates to a composition which comprises a mixture which comprises or, alternatively, consists of an extract (a) of a fruit of at least one plant of the genus Vaccinium and at least one ingredient (b) acceptable for pharmaceutical or food use and the use thereof in the prevention and/or treatment of diverticular disease or of a pathology deriving therefrom or correlated thereto.
    Type: Application
    Filed: December 1, 2017
    Publication date: February 27, 2020
    Inventors: Andrea BIFFI, Ruggero ROSSI, Walter FIORE, Silvia SALAMINA
  • EXOPOLYSACCHARIDES AND USES THEREOF
    Publication number: 20190345268
    Abstract: The present invention refers to exopolysaccharide molecules, conditioned media or compositions comprising said molecules or media. Moreover, the present invention refers to use of said exopolysaccharide molecules, conditioned media or compositions as prebiotic, preferably to boost immune system.
    Type: Application
    Filed: December 1, 2017
    Publication date: November 14, 2019
    Inventors: Andrea BIFFI, Ruggero ROSSI, Walter FIORE, Simone Domenico GUGLIELMETTI, Silvia BALZARETTI
  • NEW MEDICAL USE OF PROBIOTICS
    Publication number: 20190290706
    Abstract: The present invention relates to the use of a composition based on bacteria and/or yeasts and/or other microorganisms, taken singularly or in combination, for the treatment of the symptoms of and/or for treating Irritable Bowel Syndrome (IBS) or also similar pathologies affecting the gastrointestinal apparatus. In particular, the bacteria are selected from the following genera: Lactobacillus, Bifidobacterium, Bacillus, Propionibacterium, Streptococcus, Lactococcus, Aerococcus and Enterococcus.
    Type: Application
    Filed: June 8, 2017
    Publication date: September 26, 2019
    Applicant: SoFar S.p.A.
    Inventors: Andrea BIFFI, Walter FIORE, Ruggero ROSSI
  • METHOD FOR EVALUATING THE EFFECTS OF A COMPOSITION COMPRISING MICROORGANISMS ON INTESTINAL MICROBIOTA
    Publication number: 20160348155
    Abstract: The present invention relates to a method for determining the probiotic/paraprobiotic activity of a composition comprising microorganisms, in particular bacteria, said method being based on evaluating, by metagenomic analysis, the qualitative and/or quantitative change in faecal microbiota following intake of the composition. Moreover, the present invention relates to a kit for carrying out said method.
    Type: Application
    Filed: September 5, 2014
    Publication date: December 1, 2016
    Inventors: Simone Domenico GUGLIELMETTI, Ruggero ROSSI, Walter FIORE, Andrea BIFFI
  • USE OF A COMPOSITION COMPRISING MICROORGANISMS TO INCREASE THE INTESTINAL PRODUCTION OF BUTYRIC ACID, FOLIC ACID OR NIACIN AND/OR DECREASE THE INTESTINAL PRODUCTION OF SUCCINIC ACID
    Publication number: 20160296569
    Abstract: The present invention relates to the use of a composition comprising bacteria to increase the intestinal production of butyric acid, folic acid or niacin and/or to decrease the intestinal production of succinic acid. Moreover, the present invention relates to the use of said composition for the treatment and/or prevention of an intestinal butyrate- and/or succinate-dependent pathological condition. In particular, for the treatment and/or the prevention of intestinal inflammation, diarrhoea, ulcerative colitis or intestinal colopathies.
    Type: Application
    Filed: September 5, 2014
    Publication date: October 13, 2016
    Inventors: Simone Domenico GUGLIELMETTI, Ruggero ROSSI, Walter FIORE, Andrea BIFFI